Glauconix Biosciences has  announced the appointment of Kimberly Southern to the position of Chief Executive Officer and member of the Board of Directors, effective immediately. Southern previously held the position of Chief Operating Officer. Since…

  The global brain tumor drugs market was valued at about $2.4 billion in 2018 and is expected to grow to $3.41 billion at a CAGR of 9.2% through 2022.” — Abdul Wasay The global…